Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 529 of 5804
-
New combo therapy aims to improve AML treatment for patients with specific gene changes
Disease control Recruiting nowThis phase Ib trial tests the safety, side effects, and best dose of SNDX-5613 when given in combination with the standard chemotherapy treatment (daunorubicin and cytarabine) in treating patients with newly diagnosed acute myeloid leukemia that has changes in the NPM1 gene or ML…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Radiation boost may Re-Sensitize ovarian cancer to PARP inhibitors
Disease control Recruiting nowSOPRANO is a multi-centre phase II trial designed to assess the impact of SBRT with or without continuing treatment with a PARP inhibitor (PARPi) for patients with oligometastatic or oligoprogressive ovarian, fallopian tube and primary peritoneal carcinoma. SOPRANO will also esta…
Phase: PHASE2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New combo therapy aims to shrink inoperable esophageal tumors
Disease control Recruiting nowThis trial is conducted in patients with unresectable locally advanced esophageal squamous cell carcinoma. The investigators plan to enroll 60 patients with unresectable locally advanced esophageal cancer in Tianjin cancer hospital. After 2 cycles of induction immunochemotherapy…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for rare hormone disorder: drug targets Out-of-Control cortisol
Disease control Recruiting nowThis trial will evaluate the effects of Lu AG13909 in adult participants with Cushing's disease (CD). CD is a rare and serious disorder where the body makes too much of a hormone called cortisol. The main goals of this trial are to learn about 1. the effect of Lu AG13909 on cort…
Phase: PHASE2 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New gel could zap kidney cancer without surgery
Disease control Recruiting nowThe goal of this prospective clinical trial is to investigate the safety and efficacy of ST-02 (mucoadhesive gemcitabine suspension for pyelocaliceal instillation) to treat Upper Tract Urothelial Carcinoma (UTUC) in participants who have a low-grade tumor. The main questions thi…
Phase: PHASE2, PHASE3 • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 26, 2026 17:18 UTC
-
New program aims to cut hip fractures in nursing homes
Prevention OngoingHip fractures occur nearly twice as often for older adults residing in long-term care as they do in older adults of a similar age still living in other settings. Hip fractures are the leading cause of hospitalization and often result in loss of independence, problems with walking…
Phase: NA • Sponsor: McMaster University • Aim: Prevention
Last updated Jul 15, 2026 00:00 UTC
-
New hope for advanced breast cancer: drug combo trial shows promise
Disease control OngoingThis study is a phase II clinical trial to evaluate the safety and efficacy of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel as first-line treatment in patients with unresectable locally advanced or metastatic HER2-positive breast cancer.
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Glow-in-the-Dark drug could help brain cancer surgery
Disease control CompletedThis trial is an open-label, multicenter, phase III clinical study,conducted in patients with newly diagnosed or recurrent malignant high-grade (WHO grades 3\~4) glioma, to evaluate the efficacy and safety of a single oral dose of 5-aminolevulinic acid (5-ALA) oral solution powde…
Phase: PHASE3 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a chatbot help teens avoid eating disorders?
Prevention Recruiting nowThe purpose of this study is to test an eating disorders prevention digital chatbot program in a diverse group of adolescents.
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jul 17, 2026 00:00 UTC
-
Gene-edited stem cells: a step toward transfusion-free life for β-thalassemia?
Disease control Recruiting nowThis is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-03 (NCT06065189)
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 26, 2026 16:06 UTC
-
Heart attack patients may get safer blood thinners thanks to genetic test
Disease control Recruiting nowPatients who suffered from acute coronary syndrome (ACS) are usually treated with a long-term dual antiplatelet therapy (DAPT) to reduce stent thrombosis and recurrent ischemic event. Nonetheless, recent important data have demonstrated the efficacy of a short term DAPT and an ea…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can closing a heart hole stop strokes in seniors? new trial aims to find out
Disease control Recruiting nowPatent foramen ovale PFO closure has been shown to reduce the risk of stroke in patients with recurrent stroke. However, the majority of existing clinical studies in this field excluded patients over the age of 60 years. Data in older patients is limited and since the population …
Phase: NA • Sponsor: Josep Rodes-Cabau • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a Stress-Boosting drug make immunotherapy work for Hard-to-Treat colorectal cancer?
Disease control Recruiting nowThis Phase Ib trial studies the side effects and best dose of LB-100 when given with atezolizumab for the treatment of patients with metastatic microsatellite stable colorectal cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune syst…
Phase: PHASE1 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug aims to help short-statured children grow taller
Disease control OngoingThe intent and design of this Phase 3 study is to assess vosoritide as a therapeutic option for the treatment of children with hypochondroplasia (HCH).
Phase: PHASE3 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Eye implant could replace monthly shots for blinding disease
Disease control Recruiting nowThis study will evaluate the efficacy, safety, and PK of ranibizumab 100 milligrams per milliliter (mg/mL) delivered every 24 weeks (Q24W) via the PDS implant compared with ranibizumab 0.5 milligrams (mg) delivered every 4 weeks (Q4W) as intravitreal (IVT) injection in Chinese pa…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could an antidepressant help curb meth use in people treated for opioid addiction?
Disease control Recruiting nowThis project will evaluate the ability of Mirtazapine (MZP), a pharmacologically unique medication with a growing body of evidence to support its efficacy and safety for the treatment of methamphetamine (MA) use among medication for opioid use disorder (MOUD) patients, to signifi…
Phase: PHASE2 • Sponsor: Washington State University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can one targeted drug still work after another fails? new trial aims to find out
Disease control Recruiting nowThe purpose of this research study is to see if the medication sacituzumab govitecan (SG) is effective at the currently approved dose and schedule in people who have previously received trastuzumab deruxtecan (T-DXd) for the treatment of metastatic, hormone receptor positive (HR+…
Phase: PHASE2 • Sponsor: Reshma L. Mahtani, D.O. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug combo aims to ease heart failure symptoms and prevent hospital stays
Disease control Recruiting nowThis study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in co…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New hope for rare cancers: experimental drug ADCT-701 enters human trials
Disease control Recruiting nowBackground: Neuroendocrine neoplasms (NENs) are rare cancers in the gastrointestinal tract, pancreas, lungs, adrenal glands, and other areas of the body. Many of these cancers have a high risk of relapse and a low chance of survival. Better treatments are needed. Objective: To…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Storytelling therapy shows promise for refugee teens' mental health
Symptom relief CompletedThis study evaluated whether a culturally adapted 10-week narrative therapy program could reduce anxiety and depression symptoms among middle school students living in refugee camps in Northern Palestine. Adolescents aged 12-15 years from UNRWA-operated schools with moderate-to-s…
Phase: NA • Sponsor: Nablus University for Vocational and Technical Education • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC